Table 3. Proportion of time in therapeutic range (%) for patients on different vitamin K antagonists*.
VKA therapy | n (%) | Mean | SD | Median | Interquartile range |
---|---|---|---|---|---|
Warfarin | 6513 (66.7) | 55.4 | 28.4 | 60.8 | 35.7 to 77.6 |
Acenocoumarol | 2345 (24.0) | 52.9 | 23.7 | 54.7 | 37.4 to 70.4 |
Phenprocoumon | 672 (6.9) | 56.2 | 26.7 | 57.6 | 37.3 to 77.3 |
Other | 231 (2.4) | 59.2 | 28.1 | 65.6 | 38.9 to 80.4 |
*N = 9934; data missing for 173 patients.
SD, standard deviation; VKA, vitamin K antagonist.